References
- 1
Bausewein C, Remi C, Twycross RG. et al .
(Eds.)
Arzneimitteltherapie in der Palliativmedizin.
(German edition of Palliative Care Formulary, by Twycross RG, Wilcock A, Charlesworth
S, et al.)
- 2
Berman RM, Cappiello A, Anand A. et al .
Antidepressant effects of ketamine in depressed patients.
Biol Psychiatry.
2000;
47
351-354
- 3
Correll GE, Futter GE.
Two case studies of patients with major depressive disorder given low-dose (subanesthetic)
ketamine infusions.
Pain Med.
2006;
7
92-95
- 4
Enarson MC, Hays H, Woodroffe MA.
Clinical experience with oral ketamine.
J Pain Symptom Manage.
1999;
17
384-386
- 5
Ghai B, Grandhe RP, Kumar A. et al .
Comparative evaluation of midazolam and ketamine with midazolam alone as oral premedication.
Paediatr Anaesth.
2005;
15
554-559
- 6
Goforth HW, Holsinger T.
Rapid relief of severe major depressive disorder by use of preoperative ketamine and
electroconvulsive therapy.
J ECT.
2007;
23
23-25
- 7
Hocking G, Cousins MJ.
Ketamine in chronic pain management: an evidence-based review.
Anaesth Analg.
2003;
97
1730-1739
- 8
Liebrenz M, Stohler R, Borgeat A.
Repeated intravenous ketamine therapy in a patient with treatment-resistant major
depression.
World J Biol Psychiatry.
2007;
10
1-4
- 9
Ostroff R, Gonzales M, Sanacora G.
Antidepressant effect of ketamine during ECT.
Am J Psychiatry.
2005;
162
1385-1386
- 10
Paul R, Schaaff N, Padberg F. et al .
Comparison of racemic ketamine and S-ketamine in treatment-resistant major depression:
Report of two cases.
World J Biol Psychiatry.
2007;
1-4
- 11
Phelps LE, Brutsche N, Moral JR. et al .
Family history of alcohol dependence and initial antidepressant response to an N-methyl-d-aspartate
antagonist.
Biol Psychiatry.
2009;
65
181-184
- 12
Sinner B, Graf BM.
Ketamine.
Handb Exp Pharm.
2008;
182
313-333
- 13
Thompson C.
Onset of action of antidepressants: results of different analyses.
Hum Psychopharmacol.
2002;
17
((Suppl 1))
S27
S32
[Review]
- 14
Trivedi MH, Rush AJ, Wisniewski SR. et al .
STAR*D Study Team
Evaluation of outcomes with citalopram for depression using measurement-based care
in STAR*D: implications for clinical practice.
Am J Psychiatry.
2006;
163
28-40
- 15
Zarate Jr CA, Singh JB, Carlson PJ. et al .
A randomized trial of an N-methyl-d-aspartate antagonist in treatment-resistant major
depression.
Arch Gen Psychiatry.
2006;
63
856-864
Correspondence
G. PaslakisMD
Central Institute of Mental Health
J5
68159 Mannheim
Germany
Telefon: +49/621/1703 3823
Fax: +49/621/1703 3825
eMail: Georgios.Paslakis@zi-mannheim.de
